1. Home
  2. CCRN vs OPT Comparison

CCRN vs OPT Comparison

Compare CCRN & OPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCRN
  • OPT
  • Stock Information
  • Founded
  • CCRN 1986
  • OPT 1984
  • Country
  • CCRN United States
  • OPT Australia
  • Employees
  • CCRN N/A
  • OPT N/A
  • Industry
  • CCRN Professional Services
  • OPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CCRN Consumer Discretionary
  • OPT Health Care
  • Exchange
  • CCRN Nasdaq
  • OPT Nasdaq
  • Market Cap
  • CCRN 587.1M
  • OPT 678.6M
  • IPO Year
  • CCRN N/A
  • OPT 2020
  • Fundamental
  • Price
  • CCRN $18.22
  • OPT $5.56
  • Analyst Decision
  • CCRN Buy
  • OPT Strong Buy
  • Analyst Count
  • CCRN 3
  • OPT 1
  • Target Price
  • CCRN $18.31
  • OPT $12.00
  • AVG Volume (30 Days)
  • CCRN 473.4K
  • OPT 38.3K
  • Earning Date
  • CCRN 02-19-2025
  • OPT 02-26-2025
  • Dividend Yield
  • CCRN N/A
  • OPT N/A
  • EPS Growth
  • CCRN N/A
  • OPT N/A
  • EPS
  • CCRN N/A
  • OPT N/A
  • Revenue
  • CCRN $1,448,099,000.00
  • OPT $261,859.00
  • Revenue This Year
  • CCRN N/A
  • OPT N/A
  • Revenue Next Year
  • CCRN N/A
  • OPT $49,207.72
  • P/E Ratio
  • CCRN N/A
  • OPT N/A
  • Revenue Growth
  • CCRN N/A
  • OPT N/A
  • 52 Week Low
  • CCRN $9.58
  • OPT $1.79
  • 52 Week High
  • CCRN $22.14
  • OPT $5.90
  • Technical
  • Relative Strength Index (RSI)
  • CCRN 73.32
  • OPT 78.40
  • Support Level
  • CCRN $18.17
  • OPT $4.62
  • Resistance Level
  • CCRN $18.26
  • OPT $5.20
  • Average True Range (ATR)
  • CCRN 0.06
  • OPT 0.31
  • MACD
  • CCRN -0.14
  • OPT 0.16
  • Stochastic Oscillator
  • CCRN 60.00
  • OPT 85.83

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

About OPT Opthea Limited

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.

Share on Social Networks: